Hot Investor Mandate 3: Europe Fund Invests in Clinical-Stage Medtech and Therapeutics

8 Sep

A venture capital firm based in the United Kingdom seeks to invest in companies that need capital within the range of £1m to £10m with a typical investment size at £3 million per company. The firm focuses on investments in life science companies at clinical or growth stage. The firm has a syndicated fund of £100 million, and seeks to make 1-2 new investments within the next year in addition to their current portfolio of 8 active companies. The firm typically leads investments, though will co-invest depending on the opportunity. The firm focuses on UK-based private companies, though is open to companies based in Europe and the U.S.

The firm is currently looking for new opportunities in the Medical Technology and Therapeutics sectors. The firm will also consider diagnostics companies, depending on the opportunity. For therapeutics, the firm will invest in both small molecules and biologics. The firm will consider all classes of medical devices, and prefers to invest in devices with a regulatory pathway. The firm invests in clinical-stage to commercialized products, and prefers clinical-stage technology with a clear path towards revenue.

The firm focuses on private companies and prefers companies with a strong management team and significant growth potential that are able to deliver returns for investors within a 3 to 5-year timetable. The firm looks to take a board seat post investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: